Articles

A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar®) in the management of psoriasis with scalp involvement

Petra Staubach, Andreas Körber, Ralph M Trüeb, Caroline Mann, Ralph von Kiedrowski

Article Type

Review

Published

In this narrative review, the authors evaluate available data on the use of an innovative aerosol foam formulation of calcipotriol plus betamethasone dipropionate (Cal/BD) to treat patients with psoriasis and scalp involvement.

Read more

Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mösges, Zoltan Novak, Nikolaus Papadopoulos, Pablo Rodriguez del Rio, the Delphi Study Group

Article Type

Original Research

Published

This study analyses available evidence supporting the use of bilastine amongst second-generation antihistamines for the symptomatic treatment of allergic rhinitis and urticaria in adults and children.

Read more

Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers

David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet

Article Type

Original Research

Published

The goal of the present study was to survey patients with AD and caregivers to establish what they considered to be the most important treatment goals, thereby providing data for the systematic incorporation of these goals into Alzheimer disease clinical trials.

Read more

Assessment of knowledge, attitude and practice of fixed-dose combinations amongst attending physicians and residents: a cross-sectional evaluation

Dhyuti Gupta, Prithpal Singh Matreja, Shilpa Patrick, Meenu Thomas, Pooja Agarwal, Preeti Singh

Article Type

Original Research

Published

This study is a cross-sectional survey of physicians employed in a tertiary care teaching hospital to comprehend their level of knowledge regarding fixed-dose combinations (FDCs) as well as their attitude towards analysing the rationality of and their practice of prescribing these FDCs.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.